{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T02:53:41Z","timestamp":1721357621149},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00108-021-01102-0","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T13:05:51Z","timestamp":1626267951000},"page":"816-826","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impfung gegen humane Papillomviren"],"prefix":"10.1007","volume":"62","author":[{"given":"Peter","family":"Hillemanns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Kampers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Hachenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Jentschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"issue":"21","key":"1102_CR1","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJMoa020586","volume":"347","author":"LA Koutsky","year":"2002","unstructured":"Koutsky\u00a0LA, Ault\u00a0KA, Wheeler\u00a0CM, Brown\u00a0DR, Barr\u00a0E, Alvarez\u00a0FB et\u00a0al (2002) A controlled trial of a\u00a0human papillomavirus type 16 vaccine. N\u00a0Engl J Med 347(21):1645\u20131651","journal-title":"N Engl J Med"},{"issue":"1","key":"1102_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S1470-2045(20)30729-4","volume":"22","author":"M Das","year":"2021","unstructured":"Das\u00a0M (2021) WHO launches strategy to accelerate elimination of cervical cancer. Lancet Oncol 22(1):20\u201321","journal-title":"Lancet Oncol"},{"issue":"6","key":"1102_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","volume":"13","author":"C de Martel","year":"2012","unstructured":"de Martel\u00a0C, Ferlay\u00a0J, Franceschi\u00a0S, Vignat\u00a0J, Bray\u00a0F, Forman\u00a0D et\u00a0al (2012) Global burden of cancers attributable to infections in 2008: a\u00a0review and synthetic analysis. Lancet Oncol 13(6):607\u2013615","journal-title":"Lancet Oncol"},{"issue":"7","key":"1102_CR4","first-page":"A-282\/B-238\/C-2","volume":"113","author":"P Hillemanns","year":"2016","unstructured":"Hillemanns\u00a0P (2016) Krebsfr\u00fcherkennung: Zervixkarzinom \u2013 Doppelter Paradigmenwechsel. Dtsch Arztebl 113(7):A-282\/B-238\/C-238","journal-title":"Dtsch Arztebl"},{"key":"1102_CR5","unstructured":"Krebs in Deutschland (2015\/2016) Geb\u00e4rmutterhals C53 (krebsdaten.de). http:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Publikationen\/Krebs_in_Deutschland\/kid_2019\/kid_2019_c53_gebaermutterhals.pdf. Zugegriffen: 07. Juli 2021"},{"issue":"1","key":"1102_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers\u00a0JM, Jacobs\u00a0MV, Manos\u00a0MM, Bosch\u00a0FX, Kummer\u00a0JA, Shah\u00a0KV et\u00a0al (1999) Human papillomavirus is a\u00a0necessary cause of invasive cervical cancer worldwide. J\u00a0Pathol 189(1):12\u201319","journal-title":"J Pathol"},{"key":"1102_CR7","unstructured":"IARC (2012) IARC monographs on biological agents volume 100B: a review of human carcinogens. http:\/\/monographs.iarc.fr\/ENG\/Monographs\/vol100B\/mono100B.pdf. Zugegriffen: 4. Mai 2021"},{"issue":"4","key":"1102_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000272853","volume":"37","author":"P Hillemanns","year":"1997","unstructured":"Hillemanns\u00a0P, Thaler\u00a0C, Kimmig\u00a0R (1997) Epidemiology and diagnosis of cervical intraepithelial neoplasia\u2014Is the present concept of screening and diagnosis still current? Gynakol Geburtshilfliche Rundsch 37(4):179\u2013190","journal-title":"Gynakol Geburtshilfliche Rundsch"},{"issue":"5","key":"1102_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","volume":"9","author":"MR McCredie","year":"2008","unstructured":"McCredie\u00a0MR, Sharples\u00a0KJ, Paul\u00a0C, Baranyai\u00a0J, Medley\u00a0G, Jones\u00a0RW et\u00a0al (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a\u00a0retrospective cohort study. Lancet Oncol 9(5):425\u2013434","journal-title":"Lancet Oncol"},{"issue":"5","key":"1102_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/jnci\/djp534","volume":"102","author":"N Munoz","year":"2010","unstructured":"Munoz\u00a0N, Kjaer\u00a0SK, Sigurdsson\u00a0K, Iversen\u00a0OE, Hernandez-Avila\u00a0M, Wheeler\u00a0CM et al (2010) Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women. J\u00a0Natl Cancer Inst 102(5):325\u2013339","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1102_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","volume":"13","author":"M Lehtinen","year":"2012","unstructured":"Lehtinen\u00a0M, Paavonen\u00a0J, Wheeler\u00a0CM, Jaisamrarn\u00a0U, Garland\u00a0SM, Castellsague\u00a0X et al (2012) Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4\u2011year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 13(1):89\u201399","journal-title":"Lancet Oncol"},{"key":"1102_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-140","author":"H Ali","year":"2013","unstructured":"Ali\u00a0H, Guy\u00a0RJ, Wand\u00a0H, Read\u00a0TR, Regan\u00a0DG, Grulich\u00a0AE et al (2013) Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect Dis. https:\/\/doi.org\/10.1186\/1471-2334-13-140","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1102_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","volume":"11","author":"B Donovan","year":"2011","unstructured":"Donovan\u00a0B, Franklin\u00a0N, Guy\u00a0R, Grulich\u00a0AE, Regan\u00a0DG, Ali\u00a0H et\u00a0al (2011) Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 11(1):39\u201344","journal-title":"Lancet Infect Dis"},{"key":"1102_CR14","first-page":"CD009069","volume":"5","author":"M Arbyn","year":"2018","unstructured":"Arbyn\u00a0M, Xu\u00a0L, Simoens\u00a0C, Martin-Hirsch\u00a0PP (2018) Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev 5:CD9069","journal-title":"Cochrane Database Syst Rev"},{"key":"1102_CR15","volume-title":"Epidemiologisches Bulletin","author":"RKI","year":"2014","unstructured":"RKI (2014) Epidemiologisches Bulletin Bd. 34 (25. August 2014)"},{"key":"1102_CR16","volume-title":"Epidemiologisches Bulletin","author":"RKI","year":"2014","unstructured":"RKI (2014) Epidemiologisches Bulletin Bd. 35 (01. September 2014)"},{"key":"1102_CR17","unstructured":"(2020) Evidenz- und konsensbasierte Leitlinie Impfpr\u00e4vention HPV-assoziierter Neoplasien \u2013 Langfassung \u2013\u00a0AWMF-Register Nr.: 082-002. www.awmf.org\/uploads\/tx_szleitlinien\/082-002l_S3_Impfpraevention-HPV-assoziierter-Neoplasien_2020-07_01.pdf. Zugegriffen: 4. Mai 2021"},{"issue":"5","key":"1102_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","volume":"6","author":"LL Villa","year":"2005","unstructured":"Villa\u00a0LL, Costa\u00a0RL, Petta\u00a0CA, Andrade\u00a0RP, Ault\u00a0KA, Giuliano\u00a0AR et al (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a\u00a0randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6(5):271\u2013278","journal-title":"Lancet Oncol"},{"issue":"35\u201336","key":"1102_CR19","first-page":"584","volume":"111","author":"Y Delere","year":"2014","unstructured":"Delere\u00a0Y, Wichmann\u00a0O, Klug\u00a0SJ, van der Sande\u00a0M, Terhardt\u00a0M, Zepp\u00a0F et al (2014) The efficacy and duration of vaccine protection against human papillomavirus: a\u00a0systematic review and meta-analysis. Dtsch Arztebl Int 111(35\u201336):584\u2013591","journal-title":"Dtsch Arztebl Int"},{"issue":"16","key":"1102_CR20","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.vaccine.2020.11.076","volume":"39","author":"DR Brown","year":"2021","unstructured":"Brown\u00a0DR, Joura\u00a0EA, Yen\u00a0GP, Kothari\u00a0S, Luxembourg\u00a0A, Saah\u00a0A et al (2021) Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence. Vaccine 39(16):2224\u20132236","journal-title":"Vaccine"},{"issue":"14","key":"1102_CR21","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","volume":"383","author":"J Lei","year":"2020","unstructured":"Lei\u00a0J, Ploner\u00a0A, Elfstrom\u00a0KM, Wang\u00a0J, Roth\u00a0A, Fang\u00a0F et\u00a0al (2020) HPV vaccination and the risk of invasive cervical cancer. N\u00a0Engl J Med 383(14):1340\u20131348","journal-title":"N Engl J Med"},{"issue":"7","key":"1102_CR22","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/jnci\/djaa209","volume":"113","author":"C Dehlendorff","year":"2021","unstructured":"Dehlendorff C, Baandrup L, Kjaer SK (2021) Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers. J Natl Cancer Inst 113(7):869\u2013874. https:\/\/doi.org\/10.1093\/jnci\/djaa209","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"1102_CR23","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jama.298.7.743","volume":"298","author":"A Hildesheim","year":"2007","unstructured":"Hildesheim\u00a0A, Herrero\u00a0R, Wacholder\u00a0S, Rodriguez\u00a0AC, Solomon\u00a0D, Bratti\u00a0MC et\u00a0al (2007) Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a\u00a0randomized trial. JAMA 298(7):743\u2013753","journal-title":"JAMA"},{"key":"1102_CR24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1055\/s-0034-1368588","volume":"74","author":"P Hillemanns","year":"2014","unstructured":"Hillemanns\u00a0P (2014) Ist eine HPV-Impfung nach Konisation sinnvoll? Geburtshilfe Frauenheilkd 74:710\u2013711","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"1102_CR25","unstructured":"(2018) Epidemiologisches Bulletin. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2018\/Ausgaben\/26_18.pdf?__blob=publicationFile. Zugegriffen: 4. Mai 2021"},{"key":"1102_CR26","unstructured":"IARC Monographs (2017) List of classifications by cancer site. https:\/\/monographs.iarc.who.int\/wp-content\/uploads\/2019\/07\/Classifications_by_cancer_site.pdf. Zugegriffen: 4. Mai 2021"},{"issue":"6","key":"1102_CR27","doi-asserted-by":"publisher","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","volume":"107","author":"M Saraiya","year":"2015","unstructured":"Saraiya\u00a0M, Unger\u00a0ER, Thompson\u00a0TD, Lynch\u00a0CF, Hernandez\u00a0BY, Lyu\u00a0CW et al (2015) US assessment of HPV types in cancers: implications for current and 9\u2011valent HPV vaccines. J\u00a0Natl Cancer Inst 107(6):djv86","journal-title":"J Natl Cancer Inst"},{"key":"1102_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1098-3","author":"T Harder","year":"2018","unstructured":"Harder\u00a0T, Wichmann\u00a0O, Klug\u00a0SJ, van der Sande\u00a0MAB, Wiese-Posselt\u00a0M (2018) Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a\u00a0systematic review. BMC Med. https:\/\/doi.org\/10.1186\/s12916-018-1098-3","journal-title":"BMC Med"},{"issue":"3","key":"1102_CR29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41416-019-0602-7","volume":"122","author":"ME Sabatini","year":"2020","unstructured":"Sabatini\u00a0ME, Chiocca\u00a0S (2020) Human papillomavirus as a\u00a0driver of head and neck cancers. Br J Cancer 122(3):306\u2013314","journal-title":"Br J Cancer"},{"key":"1102_CR30","unstructured":"Epidemiologisches Bulletin 32\/33. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2020\/Ausgaben\/32-33_20.pdf?__blob=publicationFile. Zugegriffen: 4. Mai 2021"},{"issue":"9783","key":"1102_CR31","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","volume":"377","author":"JM Brotherton","year":"2011","unstructured":"Brotherton\u00a0JM, Fridman\u00a0M, May\u00a0CL, Chappell\u00a0G, Saville\u00a0AM, Gertig\u00a0DM (2011) Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 377(9783):2085\u20132092","journal-title":"Lancet"},{"key":"1102_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-227","author":"DM Gertig","year":"2013","unstructured":"Gertig\u00a0DM, Brotherton\u00a0JM, Budd\u00a0AC, Drennan\u00a0K, Chappell\u00a0G, Saville\u00a0AM (2013) Impact of a\u00a0population-based HPV vaccination program on cervical abnormalities: a\u00a0data linkage study. BMC Med. https:\/\/doi.org\/10.1186\/1741-7015-11-227","journal-title":"BMC Med"},{"key":"1102_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-87","author":"Y Delere","year":"2014","unstructured":"Delere\u00a0Y, Remschmidt\u00a0C, Leuschner\u00a0J, Schuster\u00a0M, Fesenfeld\u00a0M, Schneider\u00a0A et al (2014) Human papillomavirus prevalence and probable first effects of vaccination in 20 to 25\u00a0year-old women in Germany: a\u00a0population-based cross-sectional study via home-based self-sampling. BMC Infect Dis. https:\/\/doi.org\/10.1186\/1471-2334-14-87","journal-title":"BMC Infect Dis"},{"key":"1102_CR34","volume-title":"Jahrestagung der Deutschen Gesellschaft f\u00fcr Epidemiologie","author":"R Mikolajczyk","year":"2012","unstructured":"Mikolajczyk\u00a0R (2012) Auswirkungen der HPV-Impfung auf die Inzidenz von anogenitalen Warzen \u2013 eine Auswertung von Abrechnungsdaten einer Krankenkasse. In: Jahrestagung der Deutschen Gesellschaft f\u00fcr Epidemiologie (Abstr. V136)"},{"key":"1102_CR35","unstructured":"https:\/\/www.g-ba.de\/downloads\/39-261-2224\/2015-03-19_IQWiG-Beauftragung_Einladung-Info-Zervixkarzinom-Sc_WZ.pdf. Zugegriffen: 4. Mai 2021"},{"key":"1102_CR36","doi-asserted-by":"publisher","first-page":"106321","DOI":"10.1016\/j.ypmed.2020.106321","volume":"144","author":"BJ Kuter","year":"2021","unstructured":"Kuter\u00a0BJ, Garland\u00a0SM, Giuliano\u00a0AR, Stanley\u00a0MA (2021) Current and future vaccine clinical research with the licensed 2\u2011, 4\u2011, and 9\u2011valent VLP HPV vaccines: What\u2019s ongoing, what\u2019s needed? Prev Med 144:106321","journal-title":"Prev Med"},{"issue":"1","key":"1102_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd\u00a0EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16(1):1\u201317. https:\/\/doi.org\/10.1128\/CMR.16.1.1-17.2003","journal-title":"Clin Microbiol Rev"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-021-01102-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01102-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T11:03:58Z","timestamp":1627038238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-021-01102-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1102"],"URL":"https:\/\/doi.org\/10.1007\/s00108-021-01102-0","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]},"assertion":[{"value":"29 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Hillemanns: Vortragshonorar Roche, MSD. J.\u00a0Kampers, J.\u00a0Hachenberg und M.\u00a0Jentschke geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}